Literature DB >> 12643128

The role of the immune system in the insulin resistance syndrome.

Michael R Lewis1, Russell P Tracy.   

Abstract

The complex relationship between immunity and the insulin resistance syndrome is likely mediated to a significant degree by cytokines and the inflammatory proteins they induce. Epidemiologic work has revealed associations between cytokines and clinically evident insulin resistance, and mechanistic studies have yielded insight into the induction of insulin resistance at the cellular level by cytokines such as tumor necrosis factor-alpha. Genetic polymorphisms significantly influence this relationship, and variations in cellular immunity as manifested by T-helper cell phenotype are likely to be important as well. Further elucidation of the link between immunity and insulin resistance may lead to more effective treatment, and potentially prevention, of the insulin resistance syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12643128     DOI: 10.1007/s11892-002-0064-8

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  34 in total

1.  Allele typing of human TNFA 5'-flanking region using polymerase chain reaction-preferential homoduplex formation assay (PCR-PHFA): linkage disequilibrium with HLA class I and class II genes in Japanese.

Authors:  M Matsushita; N Tsuchiya; T Nakayama; J Ohashi; T Shibue; M Shiota; T Oka; A Yamane; K Tokunaga
Journal:  Tissue Antigens       Date:  1999-11

2.  Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.

Authors:  J P Bastard; C Jardel; E Bruckert; P Blondy; J Capeau; M Laville; H Vidal; B Hainque
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

3.  Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.

Authors:  I Barroso; M Gurnell; V E Crowley; M Agostini; J W Schwabe; M A Soos; G L Maslen; T D Williams; H Lewis; A J Schafer; V K Chatterjee; S O'Rahilly
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

4.  Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes.

Authors:  P Zimmet; R Turner; D McCarty; M Rowley; I Mackay
Journal:  Diabetes Care       Date:  1999-03       Impact factor: 19.112

5.  Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study.

Authors:  M I Schmidt; B B Duncan; A R Sharrett; G Lindberg; P J Savage; S Offenbacher; M I Azambuja; R P Tracy; G Heiss
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

Review 6.  Control of vascular cell proliferation and migration by PPAR-gamma: a new approach to the macrovascular complications of diabetes.

Authors:  W A Hsueh; S Jackson; R E Law
Journal:  Diabetes Care       Date:  2001-02       Impact factor: 19.112

7.  Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance.

Authors:  R A Mooney; J Senn; S Cameron; N Inamdar; L M Boivin; Y Shang; R W Furlanetto
Journal:  J Biol Chem       Date:  2001-05-07       Impact factor: 5.157

8.  Interleukin-6 gene polymorphism and insulin sensitivity.

Authors:  J M Fernández-Real; M Broch; J Vendrell; C Gutiérrez; R Casamitjana; M Pugeat; C Richart; W Ricart
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

9.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

10.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

View more
  1 in total

1.  Deciphering normal blood gene expression variation--The NOWAC postgenome study.

Authors:  Vanessa Dumeaux; Karina S Olsen; Gregory Nuel; Ruth H Paulssen; Anne-Lise Børresen-Dale; Eiliv Lund
Journal:  PLoS Genet       Date:  2010-03-12       Impact factor: 5.917

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.